AI-generated summary
The authors studied whether low level laser therapy could reduce bronchial hyper-responsiveness triggered by tumour necrosis factor-alpha in 28 rats, using isolated bronchial smooth muscle and cells. They report that laser treatment reduced the increased contraction and inositol phosphate accumulation seen after tumour necrosis factor-alpha exposure. The study was conducted in rats and isolated tissue, so the findings may not apply to humans.
- Who or what was studied
- 28 Wistar rats, randomly divided into four groups; isolated bronchial smooth muscle and bronchial smooth muscle cells from these animals
- Limits stated in the abstract
- The study was conducted in rats and isolated bronchial tissue and cells, so results may not translate to humans.
Written by an AI model from this paper’s abstract only and checked automatically against it, but it can still be wrong. It is not medical advice. Read the full paper. See the editorial policy.
Abstract
The full abstract is not shown here because it is protected by the publisher’s copyright. Read it on link.springer.com.
Record from PubMed, a service of the National Library of Medicine.
How to read a single study: what to check before relying on this kind of research.
Terms in this paper: Laser, Low-level laser therapy, Dose. Each links to its definition in the glossary.
A summary of published research, not medical advice. One study rarely settles a question. See the disclaimer and how to read research.